These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3437813)
1. Nitroxides as potential contrast enhancing agents for MRI application: influence of structure on the rate of reduction by rat hepatocytes, whole liver homogenate, subcellular fractions, and ascorbate. Keana JF; Pou S; Rosen GM Magn Reson Med; 1987 Dec; 5(6):525-36. PubMed ID: 3437813 [TBL] [Abstract][Full Text] [Related]
2. Influence of structure on the reduction of nitroxide MRI contrast-enhancing agents by ascorbate. Keana JF; Van Nice FL Physiol Chem Phys Med NMR; 1984; 16(6):477-80. PubMed ID: 6537509 [TBL] [Abstract][Full Text] [Related]
10. Hydrophilic Reduction-Resistant Spin Labels of Pyrrolidine and Pyrroline Series from 3,4-Bis-hydroxymethyl-2,2,5,5-tetraethylpyrrolidine-1-oxyl. Usatov MS; Dobrynin SA; Polienko YF; Morozov DA; Glazachev YI; An'kov SV; Tolstikova TG; Gatilov YV; Bagryanskaya IY; Raizvikh AE; Bagryanskaya EG; Kirilyuk IA Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338825 [TBL] [Abstract][Full Text] [Related]
11. Effect of relative configuration of TEMPO-type nitroxides on ascorbate reduction. Azuma R; Yamasaki T; Emoto MC; Sato-Akaba H; Sano K; Munekane M; Fujii HG; Mukai T Free Radic Biol Med; 2023 Jan; 194():114-122. PubMed ID: 36442586 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of nitroxide spin labels in subcellular fraction of rat liver. I. Reduction by microsomes. Iannone A; Tomasi A; Vannini V; Swartz HM Biochim Biophys Acta; 1990 Jun; 1034(3):285-9. PubMed ID: 2114173 [TBL] [Abstract][Full Text] [Related]
13. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents. Hyodo F; Matsumoto K; Matsumoto A; Mitchell JB; Krishna MC Cancer Res; 2006 Oct; 66(20):9921-8. PubMed ID: 17047054 [TBL] [Abstract][Full Text] [Related]
14. Cellular metabolism of proxyl nitroxides and hydroxylamines. Sentjurc M; Pecar S; Chen K; Wu M; Swartz H Biochim Biophys Acta; 1991 Mar; 1073(2):329-35. PubMed ID: 1849007 [TBL] [Abstract][Full Text] [Related]
15. Nitroxide-doped liposomes containing entrapped oxidant: an approach to the "reduction problem" of nitroxides as MRI contrast agents. Keana JF; Pou S Physiol Chem Phys Med NMR; 1985; 17(2):235-40. PubMed ID: 3001795 [TBL] [Abstract][Full Text] [Related]
16. Cellular metabolism of water-soluble nitroxides: effect on rate of reduction of cell/nitroxide ratio, oxygen concentrations and permeability of nitroxides. Swartz HM; Sentjurc M; Morse PD Biochim Biophys Acta; 1986 Aug; 888(1):82-90. PubMed ID: 3741890 [TBL] [Abstract][Full Text] [Related]
17. Differential clearance of nitroxide MRI contrast agents from rat cerebral ventricles. Wan X; Fu TC; Funk A; London RE Brain Res Bull; 1995; 36(1):91-6. PubMed ID: 7882056 [TBL] [Abstract][Full Text] [Related]
19. Spin probe reduction in cells and tissues. Kveder M; Sentjurc M; Schara M Magn Reson Med; 1988 Nov; 8(3):241-7. PubMed ID: 3205154 [TBL] [Abstract][Full Text] [Related]
20. Kinetics of nitroxide spin label removal in biological systems: an in vitro and in vivo ESR study. Vianello F; Momo F; Scarpa M; Rigo A Magn Reson Imaging; 1995; 13(2):219-26. PubMed ID: 7739363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]